SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 57 filers reported holding SAVARA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,766,003 | -7.4% | 1,789,948 | -21.7% | 0.02% | 0.0% |
| Q2 2023 | $7,305,058 | +32.4% | 2,286,403 | -19.2% | 0.02% | +26.3% |
| Q1 2023 | $5,517,194 | +4.4% | 2,829,330 | -17.0% | 0.02% | 0.0% |
| Q4 2022 | $5,282,225 | -50.3% | 3,407,887 | -50.3% | 0.02% | -9.5% |
| Q3 2022 | $10,621,633 | +2.4% | 6,852,430 | +0.4% | 0.02% | +10.5% |
| Q2 2022 | $10,370,448 | +13.8% | 6,822,958 | -1.9% | 0.02% | +46.2% |
| Q1 2022 | $9,111,960 | +111.3% | 6,955,664 | +100.0% | 0.01% | +18.2% |
| Q4 2021 | $4,312,000 | +1.9% | 3,477,795 | +13.5% | 0.01% | -8.3% |
| Q3 2021 | $4,230,000 | -57.9% | 3,065,304 | -48.1% | 0.01% | -14.3% |
| Q2 2021 | $10,038,000 | +51.9% | 5,904,460 | +85.9% | 0.01% | -30.0% |
| Q1 2021 | $6,607,000 | +203.1% | 3,176,422 | +67.6% | 0.02% | +185.7% |
| Q4 2020 | $2,180,000 | +42.4% | 1,895,554 | +35.0% | 0.01% | +16.7% |
| Q3 2020 | $1,531,000 | -78.2% | 1,404,519 | -50.3% | 0.01% | -57.1% |
| Q2 2020 | $7,032,000 | +23.7% | 2,824,474 | +5.3% | 0.01% | 0.0% |
| Q1 2020 | $5,686,000 | – | 2,681,992 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |